Multi-Interventional program for prevention and early Management of Anastomotic leakage after total mesorectal excision in Rectal cancer patIents, IMARI-trial
Recruiting
- Conditions
- Rectal cancer1001799110017998
- Registration Number
- NL-OMON55903
- Lead Sponsor
- Academisch Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 488
Inclusion Criteria
Patients with primary rectal cancer and scheduled for a total mesorectal
excision with planned restoration of bowel continuity or for completion total
mesorectal excision after previous local excision or regrowth in a watch and
wait protocol.
Exclusion Criteria
Patients not undergoing colorectal/-anal anastomosis;
Local recurrent rectal cancer, or redo surgery;
Locally advanced rectal cancer requiring extended or multi-visceral excision.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The primary endpoint of the IMARI-trial is anastomotic integrity at one year<br /><br>postoperative.</p><br>
- Secondary Outcome Measures
Name Time Method